Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 7/20 | 0.43 |
| ▸ | FEN1 | P39748 | 7/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20687907 | 1.00 | ALOX5AP (0.43) | ALOX5APFEN1GRM4PDE10A | |
| SCHEMBL4967417 | 0.93 | ALOX5AP (0.46) | ALOX5APFEN1GRM4 | |
| SCHEMBL20240553 | 0.93 | ALOX5AP (0.46) | ALOX5APFEN1GRM4 | |
| SCHEMBL2369803 | 0.92 | GRM4 (0.40) | ALOX5APFEN1GRM4PDE10A | |
| SCHEMBL20689383 | 0.92 | ALOX5AP (0.42) | ALOX5APFEN1GRM4PDE10A | |
| Hydrochloric Acid SCHEMBL4714047 | 0.92 | FEN1 (0.50) | ALOX5APFEN1GRM4PDE10A | |
| SCHEMBL2379480 | 0.92 | GRM4 (0.40) | ALOX5APFEN1GRM4PDE10A | |
| Hydrochloric Acid SCHEMBL4714045 | 0.92 | FEN1 (0.50) | ALOX5APFEN1GRM4PDE10A | |
| SCHEMBL9574598 | 0.91 | ALOX5AP (0.47) | ALOX5APFEN1GRM4 | |
| SCHEMBL29445482 | 0.88 | GRM4 (0.53) | ALOX5APFEN1GRM4PDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320204-A1 | 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | RIBOSCIENCE LLC (US) | 2025-10-16 | — | — | US | disclosed |
| WO-2025215153-A1 | PRMT5 INHIBITORS | Ryvu Therapeutics S.A. (PL) | 2025-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320204-A1 | 7-AZA BICYCLIC HETEROARYL DERIVATIVES AS ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1 INHIBITORS | ENPP1, ENPP3, PDE7A | ALOX5AP 370/4885FEN1 169/4885GRM4 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.